Basic Information
| RNALocate ID: | RLID:11003523 |
| RNA Symbol: | hsa-miR-769-5p |
| Localization: | Microvesicle |
RNA Information
| RNA Name: | hsa-miR-769-5p |
| RNA ID: | miRBase:MIMAT0003886 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 23539611 |
| Tissue/Cell Line: | Seminal plasma |
| Method: | Microarray |
| Description: | In order to assess the reversibility of post-vasectomy miRNA sequelae, we investigated whether SMV miRNAs altered by vasectomy could be retrieved in SMVs from normospermic vasovasostomized donors. miRNA microarray profiling performed on SMVs from normal, vasectomized and vasovasostomized donors identified 313 miRNAs whose intensity was above the threshold of detection. Among these miRNAs, 293 were detected in samples from normal donors, 275 in vasectomized donors and 298 in vasovasostomized donors (Fig. 3, Supplementary data, Table SIV). Data are collected from Table S4. |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:01002543 | Mitochondrion | Skeletal muscle myoblasts | 21637849 |
| RLID:11003521 | Exosome | B cell line (Raji)|Primary dendritic cells|T cell line (J77) | 21505438 |
| RLID:11003522 | Exosome | Plasma | 23663360 |
| RLID:11003524 | Microvesicle | Follicular fluid | 23666971 |
| RLID:11003525 | Microvesicle | Cerebrospinal fluid | 24797360 |
| RLID-D:11000175 | Exosome | B lymphoblastoid cells|Endothelial cells|Lymphoma tissue|Mast cells|Tongue tissue | |
| RLID-D:11000560 | Microvesicle | Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-769-5p | High-grade serous ovarian carcinoma | MNDR-E-MI-69329 |
| MNDR | hsa-miR-769-5p | Uterine corpus endometrial carcinoma | MNDR-E-MI-69330 |
| MNDR | hsa-miR-769-5p | Lymphoma | MNDR-E-MI-69331 |
| MNDR | hsa-miR-769-5p | Estrogen-receptor positive breast cancer | MNDR-E-MI-69332 |
| MNDR | hsa-miR-769-5p | Estrogen-receptor negative breast cancer | MNDR-E-MI-69333 |
| MNDR | hsa-miR-769-5p | Progesterone-receptor positive breast cancer | MNDR-E-MI-69334 |
| MNDR | hsa-miR-769-5p | Progesterone-receptor negative breast cancer | MNDR-E-MI-69335 |
| MNDR | hsa-miR-769-5p | Breast cancer luminal | MNDR-E-MI-69336 |
| MNDR | hsa-miR-769-5p | Prostate cancer | MNDR-E-MI-69337 |
| MNDR | hsa-miR-769-5p | Gastric cancer | MNDR-E-MI-69338 |
| MNDR | hsa-miR-769-5p | Alzheimer disease | MNDR-E-MI-69339 |
| MNDR | hsa-miR-769-5p | Intracranial aneurysm | MNDR-E-MI-69340 |
| MNDR | hsa-miR-769-5p | Head and neck cancer | MNDR-E-MI-69341 |
| MNDR | hsa-miR-769-5p | Leukemia | MNDR-E-MI-69342 |
| MNDR | hsa-miR-769-5p | Cardiovascular disease | MNDR-E-MI-69343 |
| MNDR | hsa-miR-769-5p | Lung cancer | MNDR-E-MI-69344 |
| MNDR | hsa-miR-769-5p | Parkinson disease | MNDR-E-MI-69345 |
| MNDR | hsa-miR-769-5p | Breast cancer | MNDR-E-MI-69346 |
| MNDR | hsa-miR-769-5p | Pituitary neoplasms | MNDR-E-MI-69347 |
| MNDR | hsa-miR-769-5p | Pancreatic cancer | MNDR-E-MI-69348 |
| MNDR | hsa-miR-769-5p | Rectum adenocarcinoma | MNDR-E-MI-69349 |
| MNDR | hsa-miR-769-5p | Colon cancer | MNDR-E-MI-69350 |
| MNDR | hsa-miR-769-5p | Colon adenocarcinoma | MNDR-E-MI-69351 |
| MNDR | hsa-miR-769-5p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-69352 |
| MNDR | hsa-miR-769-5p | Ovarian cancer | MNDR-E-MI-69353 |
| MNDR | hsa-miR-769-5p | Acromegaly | MNDR-E-MI-69354 |
| MNDR | hsa-miR-769-5p | Carcinoma ductal breast | MNDR-E-MI-69355 |
| MNDR | hsa-miR-769-5p | Malignant glioma | MNDR-E-MI-69356 |
| MNDR | hsa-miR-769-5p | Osteosarcoma | MNDR-E-MI-69357 |
| MNDR | hsa-miR-769-5p | Pituitary adenoma | MNDR-E-MI-69358 |
| MNDR | hsa-miR-769-5p | Lung squamous cell carcinoma | MNDR-E-MI-69359 |
| MNDR | hsa-miR-769-5p | Non-small cell lung cancer | MNDR-E-MI-69360 |
| MNDR | hsa-miR-769-5p | Lung adenocarcinoma | MNDR-E-MI-69361 |
| MNDR | hsa-miR-769-5p | Adrenocortical cancer | MNDR-E-MI-69362 |
| MNDR | hsa-miR-769-5p | Thyroid carcinoma | MNDR-E-MI-69363 |
| MNDR | hsa-miR-769-5p | Ovarian carcinoma | MNDR-E-MI-69364 |
| MNDR | hsa-miR-769-5p | Pancreatic adenocarcinoma | MNDR-E-MI-69365 |
| MNDR | hsa-miR-769-5p | Carcinoma renal cell | MNDR-E-MI-69366 |
| MNDR | hsa-miR-769-5p | Kidney renal papillary cell carcinoma | MNDR-E-MI-69367 |
| MNDR | hsa-miR-769-5p | Renal clear cell carcinoma | MNDR-E-MI-69368 |
| MNDR | hsa-miR-769-5p | Cholangiocarcinoma | MNDR-E-MI-69369 |
| MNDR | hsa-miR-769-5p | Liver cirrhosis | MNDR-E-MI-69370 |
| MNDR | hsa-miR-769-5p | Lung small cell carcinoma | MNDR-E-MI-69371 |
| MNDR | hsa-miR-769-5p | Synovial sarcoma | MNDR-E-MI-69372 |
| MNDR | hsa-miR-769-5p | Head and neck squamous cell carcinoma | MNDR-E-MI-69373 |
| MNDR | hsa-miR-769-5p | Growth hormone-secreting pituitary adenoma | MNDR-E-MI-69374 |
| MNDR | hsa-miR-769-5p | Adenoma | MNDR-E-MI-69375 |
| MNDR | hsa-miR-769-5p | Breast invasive carcinoma | MNDR-E-MI-69376 |
| MNDR | hsa-miR-769-5p | Hepatocellular carcinoma | MNDR-E-MI-69377 |
| MNDR | hsa-miR-769-5p | Rheumatoid arthritis | MNDR-E-MI-69378 |
| MNDR | hsa-miR-769-5p | Hodgkin lymphoma | MNDR-E-MI-69379 |
| MNDR | hsa-miR-769-5p | Skin cutaneous melanoma | MNDR-E-MI-69380 |
| MNDR | hsa-miR-769-5p | Skin melanoma | MNDR-E-MI-69381 |
| MNDR | hsa-miR-769-5p | Acute myeloid leukemia | MNDR-E-MI-69382 |
| MNDR | hsa-miR-769-5p | Colorectal cancer | MNDR-E-MI-69383 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | GSK3B | Homo sapiens | RR00644438 |
TOP